Conference abstract · 7 Nov 2016
Conference abstractPublished 7 Nov 2016
Monitoring onset of bone healing kinetics and early transplant rejection using implantable titanium dioxide-coated bioimpedance sensors
Vienna University of Technology, Austria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In Western societies the steady increase in human life expectancy is posing a significant socioeconomic challenge to maintain existing medical therapy standards and health care solutions for senior patients. It is also well known that elderly patients exhibit a significantly higher risk of complications following surgery. To prevent postoperative and long-term medical complications, an important strategy of medical traumatology involves repeated follow-up examinations using a variety of in vivo imaging technologies and in vitro assessment methods of biopsies. To improve early diagnosis of failed implant integration and tissue rejection, we have developed two implantable titanium dioxide-coated bioimpedance sensors to enable personalized therapeutic interventions during (1) impaired bone healing and (2) organ transplant rejection. (1) In the case of endosseous implants, which are routinely applied in tissue reconstruction after long bone, spine and craniomaxillofacial injuries, the development of a prognostic non-invasive imaging technology capable of monitoring dynamic bone formation in situ is expected to deepen our understanding of osseous integration at the implant-tissue biointerface. Results of our study revealed distinct differences between granulation and soft tissue formation within two weeks after implantation, thus allowing the accurate assessment of bone healing prior the formation of a cortical bone layer in subcritical defects of rabbit calvaria. (2) Every transplanted tissue and solid organ bears the risk of rejection, which can finally result in the loss of the transplant with falling back into disability or even death. Tissue biopsies are used today to detect and monitor tissue or solid organ rejection episodes. Detection of early stages of rejection and continuous monitoring can therefore prevent severe organ impairment or even loss of function. To overcome limitations of the state of the art rejection monitoring methods, we have developed titanium-dioxide coated implantable biosensors for transplant rejection monitoring.
Subjects
OrthopaedicsSurgeryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Nov 2016
Chips-in-organs: Monitoring onset of bone healing kinetics and early transplant rejection using implantable titanium dioxide-coated bio-impedance sensors
Case report · 15 Nov 2022
Hematuria and Fever in a Transplant Patient with Polycystic Kidney Disease and Past Borderline Cellular Rejection: A Case of Late-Onset Adenovirus Infection
Research article · 1 Oct 2021
Double layer coating system to prevent toxic reactions of titanium dioxide from the corrosion of dental implant fixtures
Research article · Jun 2010
Osteosynthesis with pure titanium implants in foot and ankle surgery
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOrthopaedics
- SubjectSurgery
- BylineArticles whose byline prints “Peter Ertl”
